| 1. |
Roncarolo, M. G. and Levings, M. (2000) The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol.
12, 676–683.
|
| |
| 2. |
Levings, M. K. and Roncarolo, M. G. (2005) Phenotypic and functional differences between human CD4+CD25+ and type 1 regulatory
T cells. Curr. Top. Microbiol. Immunol.
293, 303–326.
|
| |
| 3. |
Hauben, E. and Roncarolo, M. G. (2005) Human CD4+ regulatory T cells and activation-induced tolerance. Microbes Infect.
7, 1023–1032.
|
| |
| 4. |
Sakaguchi, S. (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and
non-self. Nat. Immunol.
6, 345–352.
|
| |
| 5. |
Fontenot, J. D. and Rudensky, A. Y. (2005) A well adapted regulatory contrivance: regulatory T cell development and the forkhead
family transcription factor Foxp3. Nat. Immunol.
6, 331–337.
|
| |
| 6. |
Baecher-Allan, C., Brown, J. A., Freeman, G. J., and Hafler, D. A. (2001) CD4+CD25high regulatory cells in human peripheral
blood. J. Immunol.
167, 1245–1253.
|
| |
| 7. |
Levings, M. K., Sangregorio, R., Sartirana, C., et al. (2002) Human CD25+CD4+ T suppressor cell clones produce transforming
growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med.
196, 1335–1346.
|
| |
| 8. |
Su, L., Creusot, R. J., Gallo, E. M., et al. (2004) Murine CD4+CD25+ regulatory T cells fail to undergo chromatin remodeling
across the proximal promoter region of the IL-2 gene. J. Immunol.
173, 4994–5001.
|
| |
| 9. |
Levings, M. K., Sangregorio, R., and Roncarolo, M. G. (2001) Human CD25+CD4+ T regulatory cells suppress naive and memory
T-cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med.
193, 1295–1302.
|
| |
| 10. |
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., and Enk, A. H. (2001) Identification and functional characterization
of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med.
193, 1285–1294.
|
| |
| 11. |
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., and Schuler, G. (2001) Ex vivo isolation and characterization of CD4(+)CD25(+)
T cells with regulatory properties from human blood. J. Exp. Med.
193, 1303–1310.
|
| |
| 12. |
Ng, W. F., Duggan, P. J., Ponchel, F., et al. (2001) Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory
T cells. Blood 98, 2736–2744.
|
| |
| 13. |
Shevach, E. M. (2002) CD4+CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol.
2, 389–400.
|
| |
| 14. |
Setoguchi, R., Hori, S., Takahashi, T., and Sakaguchi. S. (2005) Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory
T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med.
201, 723–735.
|
| |
| 15. |
Walker, M. R., Carson, B. D., Nepom, G. T., Ziegler, S. R, and Buckner. J. H. (2005) De novo generation of antigen-specific
CD4+CD25+ regulatory T cells from human CD4+CD25-cells. Proc. Natl. Acad. Sci. USA
102, 4103–4108.
|
| |
| 16. |
Walker, M. R., Kasprowicz, D. J., Gersuk, V. H., et al. (2003) Induction of FoxP3 and acquisition of T regulatory activity
by stimulated human CD4+CD25-T cells. J. Clin. Invest.
112, 1437–1443.
|
| |
| 17. |
Salomon, B., Lenschow, D. J., Rhee, L., et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+
immunoregulatory T cells that control autoimmune diabetes. Immunity
12, 431–440.
|
| |
| 18. |
Taylor, P. A., Lees, J., and Blazar. B. R. (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory
cells inhibits graft-versus-host disease lethality. Blood
99, 3493–3499.
|
| |
| 19. |
Taylor, P. A., Panoskaltsis-Mortari, A., Swedin, J. M., et al. (2004) L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory
cells are potent inhibitors of GVHD and BM graft rejection. Blood
104, 3804–3812.
|
| |
| 20. |
Ermann, J., Hoffmann, P., Edinger, M., et al. (2005) Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects
from lethal acute GVHD. Blood
105, 2220–2226.
|
| |
| 21. |
Groux, H., O’Garra, A., Bigler, M., et al. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents
colitis. Nature
389, 737–742.
|
| |
| 22. |
Vieira, P. L., Christensen, J. R., Minaee, S., et al. (2004) IL-10-secreting regulatory T cells do not express Foxp3 but have
comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J. Immunol.
172, 5986–5993.
|
| |
| 23. |
Allan, S. E., Passerini, L., Bacchetta, R., et al. (2005) The role of 2 Foxp3 isoforms in the generation of human CD4 Tregs.
J. Clin. Invest.
115, 3276–3284.
|
| |
| 24. |
Levings, M. K., Gregori, S., Tresoldi, E., Cazzaniga, S., Bonini, C., and Roncarolo, M. G. (2005) Differentiation of Tr1 cells
by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood
105, 1162–1169.
|
| |
| 25. |
Bacchetta, R., Sartirana, C., Levings, M. K., Bordignon, C., Narula, S., and Roncarolo, M. G. (2002) Growth and expansion
of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur. J. Immunol.
32, 2237–2245.
|
| |
| 26. |
Bacchetta, R., Bigler, M., Touraine, J. L., et al. (1994) High levels of interleukin 10 production in vivo are associated
with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med.
179, 493–502.
|
| |
| 27. |
McRae, B. L., Semnani, R. T., Hayes, M. P., and van Seventer, G. A. (1998) Type I IFNs inhibit human dendritic cell IL-12
production and Th1 cell development. J. Immunol.
160, 4298–4304.
|
| |
| 28. |
Levings, M., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal Malefyt, R., and Roncarolo, M. G. (2001) IFN-alpha and
IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol.
166, 5530–5539.
|
| |
| 29. |
Roncarolo, M. G., Levings, M. K., and Traversari, C. (2001) Differentiation of T regulatory cells by immature dendritic cells.
J. Exp. Med.
193, F5–F9.
|
| |
| 30. |
Akbari, O., Freeman, G. J., Meyer, E. H., et al. (2002) Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand
pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med.
8, 1024–1032.
|
| |
| 31. |
Battaglia, M., Stabilini, A., Draghici, E., et al. (2006) Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes
6, 1571–1580.
|
| |
| 32. |
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., and Sakaguchi, S. (2002) Stimulation of CD25(+)CD4(+) regulatory T cells
through GITR breaks immunological self-tolerance. Nat. Immunol.
3, 135–142.
|
| |
| 33. |
Takahashi, T., Tagami, T., Yamazaki, S., et al. (2000) Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T
cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med.
192, 303–310.
|
| |
| 34. |
Hori, S., Nomura, T., and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3.
Science
299, 1057–1061.
|
| |
| 35. |
Khattri, R., Yasayko, S. A., and Ramsdell, F. (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol.
4, 337–342.
|
| |
| 36. |
Bacchetta, R., Parkman, R., McMahon, M., et al. (1995) Dysfunctional cytokine production by host-reactive T-cell clones isolated
from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow. Blood
85, 1944–1953.
|
| |